Abstract
DMD is one of the most frequent hereditary diseases in childhood. About every 3000th to 5000th family has either a boy with DMD or a girl with carrier properties (Zellweger and Antonik 1975; Beckmann and Scheuerbrandt 1976; Emery 1977; Moser 1977; Danieli et al. 1977). DMD carriers who normally do not show clinical signs of the disease transmit DMD to 50% of their male offspring by passing on to the next generation a mutated gene located on one of their X chromosomes. Because of this sex-linked recessive mode of inheritance, DMD affects only boys. Theoretically, one-third of the DMD cases are caused by new mutations (Haldane 1935; Gardner-Medwin 1970). The rate of mutations is probably equal in both sexes (Vogel 1977). Danieli et al. (1977) and Pickard et al. (1978) suggested a lower percentage of spontaneous cases. Emery (1977) has analyzed in detail the genetics of DMD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antonik A (1977, 1978) Method for the determination of creatine phosphokinase enzyme, US patents 4,001,088, 4,080,265
Arnold H, Scheuerbrandt G, Beckmann R, Lohr GW (1978) Creatine kinase in human erythrocytes: A newly detected genetic anomaly in a clinically healthy family. Blut 37:249–256
Association francaise contre la myopathie (1977) Le courrier de la myopathie. Issue 68, p 9
Becker PE (1978) Genetische Beratung bei Myotonien und Muskeldystrophien. Internist 19:475–481
Beckmann R (1977) Myopathien. In: Keller W/Wiskott A, Lehrbuch der Kinderheilkunde. Wiskott A, Betke K, Künzer W (eds), 4th edn, Thieme, Stuttgart
Beckmann R, Scheuerbrandt G (1976) Screening auf erhöhte CK-Aktivitäten zur Früherkennung der Duchenne-Muskeldystrophie. Ergebnis einer Studie an Blutproben von 16 520 Neugeborenen. Kinderarzt 7:1267–1272
Beckmann R, Scheuerbrandt G (1977) Muskeldystrophie (Duchenne) — Früherkennung-CK-Screeningtest-Konsequenzen. Ergebnisse zweier Fragebogenaktionen. Kinderarzt 8:313–317
Beckmann R, Teirich-Leube H (1970) Die progressiven Muskeldystrophien und Möglichkeiten ihrer Behandlung: Ther Ggw 109:485–507, 648–656
Beckmann R, Scheuerbrandt G, Antonik A, Antonik S (1974) Ein neuer Kreatinkinase-Test. Kinderarzt 5:731–733
Beckmann R, Scheuerbrandt G, Beubl L (to be published) Identifizierung von Überträgerinnen der Duchenne-Muskeldystrophie
Bodensteiner J, Zellweger H (1971) Creatine phosphokinase in normal neonates and young infants. J Lab Clin Med 77:853
Chase GA, Murphy EA (1973) Risk of recurrence and carrier frequency for X-linked lethal recessives. Hum Hered 23:19–26
Danieli GA, Mostacciuolo ML, Bonfante A, Angelini C (1977) Duchenne muscular dystrophy, a population study. Hum Genet 35:225–231
Dellamonica C (1978) Etude de la réaction couplée créatine-kinase/luciférine-luciférase. Application au dépistage systématique néonatal de la myopathie de Duchenne de Boulogne. PhD Thesis, University Lyon
Dellamonica C, Robert JM, Cotte J, Collombel C, Dorche C (1978) Systematic neonatal screening for duchenne muscular dystrophy. Lancet 11:1100
Drummond LM, Veale AMO (1978) Muscular dystrophy screening. Lancet 1:1258–1259
Dubowitz V (1976) Screening for Duchenne muscular dystrophy. Arch Dis Child 51:249–251
Dubowitz V, van Iddekinge B, Rodeck CH, Campbell S, Singer JD, Scheuerbrandt G, Moss DW (1978) Prentatal diagnosis in duchenne muscular dystrophy: salvage of a normal male fetus. Lancet 1:90
EAMDA (1978) European Alliance of Muscular Dystrophy Associations, Report 3:5–15, Recent advances in the study of neuromuscular diseases
Emery AEH (1977) Genetic considerations in the X-linked muscular dystrophies. In: Rowland LP (ed) Pathogenesis of human muscular dystrophies. Exerpta Medica, Amsterdam Oxford, pp 42–58
Emery AEH, Watt MS, Clack ER (1972) The effects of genetic counselling in Duchenne muscular dystrophy. Clin Genet 3:147–150
Gardner-Medwin D (1970) Mutation rate in Duchenne type of muscular dystrophy. J. Med Genet 7:334–337
Gardner-Medwin D (1976) Duchenne muscular dystrophy: Early diagnosis and screening. Arch Dis Child 51:982–983
Gardner-Medwin D, Bundey S, Grenn S (1978) Early diagnosis of Duchenne muscular dystrophy. Lancet 1:1102
Gilboa N, Swanson JR (1976) Serum creatine phosphokinase in normal newborns. Arch Dis Child 51:283–285
Golbus MS, Stephens JD, Mahoney MJ, Hobbins JC, Haseltine FP, Caskey CT, Banker BO (to be published) Failure of fetal CPK to diagnose Duchenne’s muscular dystrophy. N Engl J Med
Haldane JBS (1935) The rate of spontaneous mutations of a human gene. J Genetics 31:317–326
Heyck H, Laudahn G, Carsten PM (1966) Enzymaktivitätsbestimmungen bei Dystrophia musculorum progressiva. Klin Wochenschr 44:695
Ionasescu V, Zellweger H, Shirk P, Conway TW (1973) Identification of carriers of Duchenne muscular dystrophy by muscle protein synthesis. Neurology 23:497–502
Ketelsen U-P (to be published) Differentialdiagnostische Bedeutung der Muskelbiopsie bei myogenen und neuromuskulären Erkrankungen: Lichtmikroskopisch-histochemische und elektronenmikroskopische Befunde. Monatsschr Kinderheilkd
Lyon MF (1962) Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 14:135
Mahoney MJ, Haseltine EP, Hobbins JC, Banker BO, Caskey CT, Golbus MS (1977) Prenatal diagnosis of Duchenne’s muscular dystrophy. N Engl J Med 297:968–973
Moser H (1977) Heterozygotenerfassung und genetische Beratung bei der progressiven Muskeldystrophie Duchenne. Schweiz Rundschau Med (Praxis) 27:814–822
Nicholson GA, Gardner-Medwin D, Pennington RJT, Walton JN (1979) Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity. Lancet 1:692–694
Pickard NA, Gruemer H-D, Verril HL, Isaacs ER, Robinow M, Nance WE, Myers E, Goldsmith B (1978) Systemic membrane defect in the proximal muscular dystrophies. N Engl J Med 299:841–846
Stengel-Rutkowski L, Scheuerbrandt G, Beckmann R, Pongratz D (1977) Prenatal diagnosis of Duchenne’s muscular dystrophy. Lancet 1:1359–1360
Vogel F (1977) A probable sex difference in some mutation rates. Am J Hum Genet 29: 312–319
Zellweger H (1976) New Tasks: Prevention of handicap. Dev Med Child Neurol 18:3–10
Zellweger H, Antonik A (1975) Newborn screening for Duchenne muscular dystrophy. Pediatrics 55:30–34
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Beckmann, R., Robert, J.M., Zellweger, H., Beubl, L., Dellamonica, C., Scheuerbrandt, G. (1980). Neonatal Screening for Muscular Dystrophy. In: Bickel, H., Guthrie, R., Hammersen, G. (eds) Neonatal Screening for Inborn Errors of Metabolism. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67488-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-67488-4_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67490-7
Online ISBN: 978-3-642-67488-4
eBook Packages: Springer Book Archive